JYEST Cell Injection Infusion
IIT2026009
Phase 1 mab active
Quick answer
JYEST Cell Injection Infusion for Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation
- Phase
- Phase 1
- Modality
- mab
- Status
- active